期刊文献+

自噬在胶质母细胞瘤中的研究进展 被引量:3

Research Advances in Autophagy in Glioblastoma
下载PDF
导出
摘要 自噬是一种通过降解和循环细胞质成分来完成细胞再利用的过程,与肿瘤的发生、发展有着密切的联系。胶质母细胞瘤(GBM)是一种侵袭性强,恶性程度高的星形细胞肿瘤。自噬的调节由多条信号通路所调控,这些信号通路也同时调节着肿瘤的发生、发展。自噬在GBM细胞中具有双重功能。少量的自噬可以增加肿瘤细胞的耐药性,从而使肿瘤得以存活。过量的自噬则可以通过自噬性死亡来杀伤肿瘤细胞。更全面地了解自噬在GBM中的作用机制,既有助于改善替莫唑胺(TMZ)的疗效,也有助于发现GBM的新的治疗方向。 Autophagy is a process of cell re-use by degrading and circulating cytoplasmic components,which is closely related to the occurrence and development of tumors.Glioblastoma(GBM) is a highly invasive and malignant astrocytoma.The regulation of autophagy is regulated by multiple signaling pathways,which also regulate the occurrence and development of tumors.Autophagy has a dual function in GBM cells.A small amount of autophagy can increase the drug resistance of tumor cells,thus allowing tumors to survive.Excessive autophagy can kill tumor cells by autophagic death.A more comprehensive understanding of the action mechanism of autophagy in GBM will help not only to improve the efficacy of temozolomide,but also to discover the new therapeutic direction of GBM.
作者 赵海杞 赵世光 石长滨 张欣健 韩大勇 滕雷 ZHAO Haiqi;ZHAO Shiguang;SHI Changbin;ZHANG Xinjian;HAN Dayong;TENG Lei(Department One of Neurosurgery,the First Affiliated Hospital of Harbin Medical University,Harbin 150001,China)
出处 《医学综述》 2019年第16期3212-3215,3220,共5页 Medical Recapitulate
基金 黑龙江省教育厅科学技术研究项目(12511z016)
关键词 胶质母细胞瘤 自噬 替莫唑胺 靶向治疗 Glioblastoma Autophagy Temozolamide Targeted therapy
  • 相关文献

参考文献2

二级参考文献128

  • 1Prados MD, Levin V. Biology and treatment of malignant glioma. Semin Oncol 2000; 27 (3 Suppl 6): s1-s10.
  • 2Gottardo NG, Gajjar A. Chemotherapy for malignant brain tumors of childhood. J Child Neurol 2008; 23:1149-1159.
  • 3Ricci MS, Zong WX. Chemotherapeutic approaches for targeting cell death pathways. Oncologist 2006; 11: 342-357.
  • 4Jiang H, White EJ, Conrad C, Gomez-Manzano C, Fueyo J. Autophagy pathways in glioblastoma. Methods Enzymol 2009; 453: 273-286.
  • 5Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 2004; 11: 448-457.
  • 6Kaicker S, McCrudden KW, Beck L, New T, Huang J, Frischer JS, et al. Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma. Int J Oncol 2003; 23: 1651-1655.
  • 7Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, et al. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme, lnt J Radiat Oncol Biol Phys 2004; 60: 353-357.
  • 8Ponten J, Westermark B. Properties of human malignant glioma cells in vitro. Med Biol 1978; 56: 184-193.
  • 9Takeuchi H, Kanzawa T, Kondo Y, Komata T, Hirohata S, Kyo S, et al. Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells. Int J Oncol 2004; 25: 57-63.
  • 10Kanzawa T, Kondo Y, Ito H, Kondo S, Germano IM, Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 2003; 63: 2103-2108.

共引文献56

同被引文献15

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部